Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era

Clinical Microbiology and Infection

Volumn 16, Issue 5, 2010, Pages 439-446

  Pedersen, T I ^a   Howitz, M ^b   Ostergaard C ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Haemophilus influenzae; Meningitis; Mortality; Vaccination

Indexed keywords

AMINOPENICILLIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PENICILLIN V;

ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; DISEASE PREDISPOSITION; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HEARING LOSS; HUMAN; INFECTION RATE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MASTOIDITIS; MORTALITY; NONHUMAN; OTITIS MEDIA; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SEROTYPE; SINUSITIS; SURVIVOR; VACCINE FAILURE;

HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 77952922176     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02841.x     Document Type: Article

References (22)

1. Garpenholt O, Hugosson S, Fredlund H, Giesecke J, Olcen P. Invasive disease due to Haemophilus influenzae type b during the first 6 years of general vaccination of Swedish children. Acta Paediatr 2000, 89:471-4.
2. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998, 17:S132-S136.
3. Campos J, Hernando M, Roman F. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol 2004, 42:524-9.
4. Peltola H, Aavitsland P, Hansen KG, Jonsdottir KE, Nokleby H, Romanus V. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis 1999, 179:223-9.
5. Global immunization data. December 2008. http://www.who.int/immunization/newsroom/global_immunization_data_december2008.pdf, WHO, Available at
6. McVernon J, Trotter CL, Slack MPE, Ramsay ME. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 2004, 329:655-8.
7. Lee YC, Kelly DF, Yu LM. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis 2008, 46:186-92.
8. Bajanca P, Canica M. Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989-2001). J Clin Microbiol 2004, 42:807-10.
9. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. Clin Infect Dis 1996, 22:1069-76.
10. Ribeiro GS, Reis JN, Cordeiro SM. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003, 187:109-16.
11. Perdue DG, Bulkow LR, Gellin BG. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA 2000, 283:3089-94.
12. Tsang RS, Sill ML, Skinner SJ, Law DK, Zhou J, Wylie J. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis 2007, 44:1611-4.
13. Meyer CN, Schonheyder HC, Bangsborg J. Bacterial meningitis in Denmark 2002-2003. A nation-wide laboratory-based registration. Ugeskr Laeger 2007, 169:503-6.
14. Kristensen K, Kaaber K, Ronne T, Larsen SO, Henrichsen J. Epidemiology of Haemophilus influenzae type b infections among children in Denmark in 1985 and 1986. Acta Paediatr Scand 1990, 79:587-92.
15. Booy R, Heath PT, Slack MP, Begg N, Richard Moxon E. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. The Lancet 1997, 349:1197-202.
16. Christiansen AH, Samuelsson S. Haemophilus influenzae meningitis 1989-2003. Epi-Nyt 2004, 19. http://www.ssi.dk/sw11467.asp, Available at
17. Heath PT, Booy R, Azzopardi HJ. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J 2001, 20:300-5.
18. Ribeiro GS, Lima JB, Reis JN. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine 2007, 25:4420-8.
19. Brouwer MC, van de Beek D, Heckenberg SG, Spanjaard L, de Gans J. Community-acquired Haemophilus influenzae meningitis in adults. Clin Microbiol Infect 2007, 13:439-42.
20. Lebel MH, Freij BJ, Syrogiannopoulos GA. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988, 319:964-71.
21. Østergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according the focus of infection. BMC Infect Dis 2005, 5:1-11.
22. Valentiner-Brandt P, Andersen PH, Glismann S, Christiansen AH, Simonsen JB. DTap/IPVl/HIB vaccination coverage by end 2007. Epi News 2008, 37. http://www.ssi.dk/sw58794.asp, Available at